Pharmaceuticals, Biotechnology and Life Sciences
Pharnext, a French biopharmaceutical company focused on drugs against neurodegenerative diseases, has been named Best Life-Sciences IPO France 2016 Award.
Dechra has issued an unaudited Trading Update covering the half year reporting period (the Period) from 1 July to 31…
Oxford Pharmascience Group has completed laboratory work to identify modifications to the OXPzero technology platform that alter the release properties and enable faster release of the NSAID.
AstraZeneca has provided updates on some of its cancer related clinical trials including 1st-line non-small cell lung cancer (NSCLC). and a…
Bavarian Nordic has appointed Henrik Birk as Chief Operating Officer, the newly created position where he will develop and lead the execution of Bavarian Nordic’s operational and HR strategies.
Onzima Ventures said on Tuestday it would buy another 51% of N4 Pharma Limited shares with 34609210 new ordinary shares of of 0.1p each in its capital. The acquisition should be completed by mid-April 2017.
Pure-play aesthetics company SInclair Pharma has reported topping out market expectations with sales in the twelve months until December 2016 being about £2m, which represents the gorwth of more than 37% to £37.8m.
Novo Nordisk has initiated a share repurchase programme in accordance with certain European regulations known as the Safe Harbour rules.
Hutchison China MediTech has appointed Paul Rutherford Carter as its Senior Independent Non-Executive Director, and a member of several its…
ConvaTec Group, a UK-based medical products and technologies company, said on Monday that it has appointed two joint corporate brokers.